Efstathios Rallis1, Elma Koumantaki-Mathioudaki, Amalia Tsiatoura, Panagiotis Stavropoulos, Andreas Katsambas. Show Affiliations » 1. 11 Pafsaniou St, Athens, Greece 11635. efrall@otenet.gr.
Abstract
Entities: Disease
Mesh： See more » Antibodies, Monoclonal/pharmacologyAntibodies, Monoclonal/therapeutic useCrohn Disease/complicationsCrohn Disease/drug therapyDermatologic Agents/pharmacologyDermatologic Agents/therapeutic useEtanerceptHumansImmunoglobulin G/pharmacologyImmunoglobulin G/therapeutic useInfliximabMaleMethotrexate/therapeutic useMiddle AgedPyoderma Gangrenosum/drug therapyPyoderma Gangrenosum/etiologyPyoderma Gangrenosum/pathologyReceptors, Tumor Necrosis Factor/therapeutic useTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances： See more » Antibodies, MonoclonalDermatologic AgentsImmunoglobulin GReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaInfliximabEtanerceptMethotrexate
Year: 2013 PMID： 24195097
Source DB: PubMed Journal: Cutis ISSN： 0011-4162